These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 18927095)
41. Predictors of intention translation in flexible sigmoidoscopy screening for colorectal cancer. von Wagner C; Bonello B; Stoffel ST; Skrobanski H; Kerrison R; McGregor LM Health Psychol; 2019 Dec; 38(12):1083-1095. PubMed ID: 31556658 [TBL] [Abstract][Full Text] [Related]
42. The impact of media coverage of the Flexible Sigmoidoscopy Trial on English colorectal screening uptake. Lo SH; Vart G; Snowball J; Halloran SP; Wardle J; von Wagner C J Med Screen; 2012 Jun; 19(2):83-8. PubMed ID: 22653573 [TBL] [Abstract][Full Text] [Related]
43. Offering people a choice for colorectal cancer screening. Senore C; Ederle A; Benazzato L; Arrigoni A; Silvani M; Fantin A; Fracchia M; Armaroli P; Segnan N Gut; 2013 May; 62(5):735-40. PubMed ID: 22442162 [TBL] [Abstract][Full Text] [Related]
44. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II. Rasmussen M; Fenger C; Kronborg O Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473 [TBL] [Abstract][Full Text] [Related]
45. Psychological effects of colorectal cancer screening: Participants Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484 [TBL] [Abstract][Full Text] [Related]
46. Outcomes for women in a flexible sigmoidoscopy-based colorectal cancer screening programme. Viiala CH; Olynyk JK Intern Med J; 2008 Feb; 38(2):90-4. PubMed ID: 17916176 [TBL] [Abstract][Full Text] [Related]
47. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening. Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179 [TBL] [Abstract][Full Text] [Related]
48. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting. Senore C; Ederle A; Fantin A; Andreoni B; Bisanti L; Grazzini G; Zappa M; Ferrero F; Marutti A; Giuliani O; Armaroli P; Segnan N J Med Screen; 2011; 18(3):128-34. PubMed ID: 22045821 [TBL] [Abstract][Full Text] [Related]
49. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Atkin WS; Cook CF; Cuzick J; Edwards R; Northover JM; Wardle J; Lancet; 2002 Apr; 359(9314):1291-300. PubMed ID: 11965274 [TBL] [Abstract][Full Text] [Related]
50. Screening sigmoidoscopy: a randomised trial of invitation style. Gray M; Pennington CR Health Bull (Edinb); 2000 Mar; 58(2):137-40. PubMed ID: 12813842 [TBL] [Abstract][Full Text] [Related]
51. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736 [TBL] [Abstract][Full Text] [Related]
52. Prospective study of predictors of attendance for breast screening in inner London. Sutton S; Bickler G; Sancho-Aldridge J; Saidi G J Epidemiol Community Health; 1994 Feb; 48(1):65-73. PubMed ID: 8138773 [TBL] [Abstract][Full Text] [Related]
53. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial). Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368 [TBL] [Abstract][Full Text] [Related]
54. Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program. Shapero TF; Hoover J; Paszat LF; Burgis E; Hsieh E; Rothwell DM; Rabeneck L Gastrointest Endosc; 2007 Apr; 65(4):640-5. PubMed ID: 17173913 [TBL] [Abstract][Full Text] [Related]
55. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. Atkin WS; Edwards R; Wardle J; Northover JM; Sutton S; Hart AR; Williams CB; Cuzick J J Med Screen; 2001; 8(3):137-44. PubMed ID: 11678553 [TBL] [Abstract][Full Text] [Related]
56. Flexible sigmoidoscopy as a screening test for colorectal cancer. Janssens JF Acta Gastroenterol Belg; 2005; 68(2):248-9. PubMed ID: 16013644 [TBL] [Abstract][Full Text] [Related]
57. Training general practitioners in flexible sigmoidoscopy to screen for colorectal cancer. Martin JA; Crotty B; Barbaro D; Higlett T; Zalcberg J ANZ J Surg; 2001 Dec; 71(12):715-9. PubMed ID: 11906385 [TBL] [Abstract][Full Text] [Related]
58. Colonoscopy conversion after flexible sigmoidoscopy screening: results from the UK Bowel Scope Screening Programme. Siau K; Yew AC; Ishaq S; Jewes S; Shetty S; Brookes M; Veitch A; McKaig B; Murugananthan A Colorectal Dis; 2018 Jun; 20(6):502-508. PubMed ID: 29205835 [TBL] [Abstract][Full Text] [Related]
59. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial. Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933 [TBL] [Abstract][Full Text] [Related]